Bull of the Day: Hims & Hers Health (HIMS)
Nasdaqarrow_outwardMorgan Stanley maintains Hims and Hers stock rating amid slowing growth
Investing.comarrow_outwardIs Hims & Hers (HIMS) Stock a Buy After the Recent Pullback? Here’s What Analysts Say
TipRanksarrow_outwardHims & Hers Health, Inc. (HIMS) Isn’t Regarded As A Great Actor By Doctors, Says Jim Cramer - Insider Monkey
Insider Monkeyarrow_outwardHIMS FRAUD ALERT: Hims & Hers Health, Inc. 34% Stock Drop - GlobeNewswire
GlobeNewswirearrow_outwardBull of the Day: Hims & Hers Health (HIMS) - Zacks Investment Research
Zacks Investment Researcharrow_outwardHims & Hers (HIMS) turns Novo Nordisk’s patent lapse into its next big bet - Investorsobserver
Investorsobserverarrow_outwardHims & Hers Health (HIMS) Stock Is Up, What You Need To Know - Barchart.com
Barchart.comarrow_outwardHims & Hers Health (HIMS) Stock Is Up, What You Need To Know - FinancialContent
FinancialContentarrow_outwardWhat's Going On With Hims & Hers Health Stock Today? - Benzinga
Benzingaarrow_outwardHims & Hers plans Canada expansion to time patent cliff for Novo’s Weogvy - Seeking Alpha
Seeking Alphaarrow_outwardHims & Hers Shares Rise on Plans to Expand Into Canada Next Year - Bloomberg
Bloombergarrow_outwardHims & Hers stock rises on planned Canadian expansion with generic semaglutide - Investing.com Canada
Investing.com Canadaarrow_outwardIs Hims & Hers Stock in Trouble? - Mitrade
Mitradearrow_outwardHims & Hers’ ugly split with Wegovy maker weighs on the telehealth company’s future - Los Angeles Times
Los Angeles Timesarrow_outwardHims & Hers Stock Tumbles as Novo Nordisk Ends Its Wegovy Sales Deal. Can the Telehealth Giant Recover? - The Motley Fool
The Motley Foolarrow_outwardHims & Hers Stock Financial Analysis Following Huge Stock Price Crash - MSN
MSNarrow_outwardHIMS Stock To $25? - Forbes
Forbesarrow_outwardWhy Hims & Hers Stock Could Be a Multi-Bagger in the Making - MarketBeat
MarketBeatarrow_outwardHims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug - Pharmaceutical Technology
Pharmaceutical Technologyarrow_outwardHims stock plunged 34%; Here’s why - INDmoney
INDmoneyarrow_outwardHims & Hers stock plunges after Novo Nordisk ends Wegovy direct sales deal - Yahoo Finance
Yahoo Financearrow_outwardStocks making the biggest moves midday: Tesla, Novo Nordisk, Hims & Hers, Northern Trust, Fiserv and more - CNBC
CNBCarrow_outwardNovo, Hims & Hers engage in war of words after Wegovy deal falls apart - Reuters
Reutersarrow_outwardHims & Hers Stock Drops More Than 30% After Novo Nordisk Breakup - WSJ - The Wall Street Journal
The Wall Street Journalarrow_outwardHims & Hers Stock Plunges 35% as Novo Nordisk Ends Partnership, Citing 'Illegal' Practices - Investopedia
Investopediaarrow_outwardNovo Nordisk halts Wegovy deal with Hims & Hers, triggering 31% stock drop - USA Today
USA Todayarrow_outwardHims & Hers stock plunges 30% as Novo Nordisk terminates Wegovy direct sales deal - Fierce Healthcare
Fierce Healthcarearrow_outwardHims & Hers stock plunges after Novo Nordisk ends its brief partnership - Business Insider
Business Insiderarrow_outwardHims & Hers’ stock plunges after Wegovy parent ends weight-loss drug partnership - MarketWatch
MarketWatcharrow_outwardHims & Hers on track for biggest drop ever after Novo Nordisk ends partnership - Sherwood News
Sherwood Newsarrow_outwardHow IBD 50's Hims & Hers Is Shaking Up The Weight-Loss Brawl - Investor's Business Daily
Investor's Business Dailyarrow_outwardWhere Will Hims & Hers Stock Be in 10 Years? - The Globe and Mail
The Globe and Mailarrow_outwardHims & Hers stock jumps after blowout quarter, long-term guidance stuns Street - Proactive financial news
Proactive financial newsarrow_outward
Hims Stock close
- 2025-07-14 22:10 event
- 34 sourceslanguage
- 100+ ads_click
- 2 days ago schedule